title: Update and evaluation of Australian guidelines. Industry perspective.
authors.affiliation: Eli Lilly Australia LTD, West Ryde, NSW, Australia.
authors.forename: B
authors.initials: B
authors.lastname: Carmine
mesh_terms: D001315:Australia; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D004345:Drug Industry / Q000458:organization & administration* / Q000639:trends*; D017408:Guidelines as Topic; D005102:Health Expenditures / Q000639:trends*; D006801:Humans; D010043:Outcome and Process Assessment, Health Care / Q000191:economics / Q000458:organization & administration*